Pharmacokinetics and Tolerability of the Novel Oral Prostacyclin IP Receptor Agonist Selexipag
Crossref DOI link: https://doi.org/10.1007/s40256-015-0117-4
Published Online: 2015-04-08
Published Print: 2015-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kaufmann, Priska
Okubo, Kaori
Bruderer, Shirin
Mant, Tim
Yamada, Tetsuhiro
Dingemanse, Jasper
Mukai, Hideya
License valid from 2015-04-08